Evidence map›Paper›PMID 41576087›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Droplet growth, Ostwald's rule, and emergence of order in Fused in Sarcoma.

Farkhad Maksudov, Mauro L Mugnai, Laura Dominguez, Dmitrii E Makarov, D Thirumalai

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Farkhad MaksudovDepartment of Chemistry, The University of Texas at Austin, Austin, TX 78712.ORCID 0000-0002-3321-9899
Mauro L MugnaiInstitute for Soft Matter Synthesis and Metrology, Georgetown University, Washington, DC 20057.ORCID 0000-0002-0267-2279
Laura DominguezDepartment of Chemistry, The University of Texas at Austin, Austin, TX 78712.ORCID 0000-0003-3666-2789
Dmitrii E MakarovDepartment of Chemistry, The University of Texas at Austin, Austin, TX 78712.ORCID 0000-0002-8421-1846
D ThirumalaiDepartment of Chemistry, The University of Texas at Austin, Austin, TX 78712.ORCID 0000-0003-1801-5924

Funding

National Science Foundation (NSF) CHE2320256National Science Foundation (NSF) CHE2400424Welch Foundation (The Welch Foundation) F-0019Welch Foundation (The Welch Foundation) F-1514
6 · The paper itself

Abstract

The low-complexity domain of Fused in Sarcoma (FUS-LC) undergoes phase separation, forming a dense, liquid-like phase that gradually matures into an ordered, gel-like state over long-time scales. During the maturation process, specific regions of the FUS-LC sequence-core-1, core-2, and core-3-become structured, giving rise to nonpolymorphic fibrils. Coarse-grained simulations predict that kinetically the least stable fibril-like core-3 forms first while the most stable core-1 appears last, in accord with Ostwald's rule of stages. The fibril structure of the C-terminal core-3, predicted using AlphaFold, shows that a [Formula: see text]-strand appears in this region early during droplet formation and triggers FUS-LC assembly. Multichain simulations, which ensure the equality of the chemical potentials between the phases, show that the dense phase forms through nucleation and coarsening, resembling Ostwald ripening. The approaches developed here are broadly applicable and could help uncover assembly mechanisms in other intrinsically disordered proteins like TDP-43, which shares key features with FUS-LC.

Indexed as

RNA-Binding Protein FUSHumansKineticsModels, MolecularPhase SeparationProtein DomainsFUS protein, humanRNA-Binding Protein FUSintrinsically disordered proteinslow-complexity sequencesOstwald’s rulephase separationrates of fibril formation

Identifiers

PMID41576087
PMCPMC12846778

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.